Asad Haider
Stock Analyst at Goldman Sachs
(1.64)
# 1113
Out of 5,317 analysts
5
Total ratings
100.00%
Success rate
3.06%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | Upgrades: Buy | 157 172 | 153.47 | 12.07% | 1 | Apr 9, 2025 | |
LLY Eli Lilly | Upgrades: Buy | 892 888 | 756.4 | 17.4% | 1 | Apr 8, 2025 | |
ABBV AbbVie | Assumes: Neutral | 194 | 176.78 | 9.74% | 1 | Apr 8, 2025 | |
PFE Pfizer | Downgrades: Neutral | 32 25 | 22.45 | 11.36% | 1 | Apr 8, 2025 | |
BMY Bristol-Myers Squibb | Downgrades: Neutral | 67 55 | 49.91 | 10.2% | 1 | Apr 8, 2025 |